Results 81 to 90 of about 367,035 (204)

A pathological control study of ultrasound attenuation imaging in assessing the degree of hepatic steatosis

肿瘤影像学, 2023
Objective: To explore the diagnostic performance of ultrasound attenuation imaging (ATI) in assessing the severity of hepatic steatosis using pathohistology as the gold standard.
ZHU Yuli, Bao Jingwen, WANG Kun, ZHAO Qiannan, XU Qingyue, WANG Wenping   +5 more
doaj  

Cellular senescence drives age-dependent hepatic steatosis [PDF]

, 2017
The incidence of non-alcoholic fatty liver disease (NAFLD) increases with age. Cellular senescence refers to a state of irreversible cell-cycle arrest combined with the secretion of proinflammatory cytokines and mitochondrial dysfunction. Senescent cells
Wilson, C.L. (Caroline L.), Allyson Palmer, Von Zglinicki, Thomas, Ogrodnik, M. (Mikolaj), Wilson, Caroline L., Hoeijmakers, Jan H J., Quentin M. Anstee, Derek A. Mann, Barnhoorn, Sander, Lahat, Albert, Tiniakos, D. (Dina), Albert Lahat, Passos, João F., Sushma Nagaraja Grellscheid, Bird, T.G. (Thomas G.), Thomas von Zglinicki, Tchkonia, T. (Tamar), Von Zglinicki, T. (Thomas), Burt, A.D. (Alastair), Hoeijmakers, J.H.J. (Jan), Kirkland, J.L. (James L.), Palmer, Allyson, Barnhoorn, S. (Sander), Hoeijmakers, Jan HJ., James L. Kirkland, Lahat, A. (Albert), Ogrodnik, Mikolaj, Anstee, Q.M. (Quentin M.), João F. Passos, Tiniakos, Dina, Day, C.P. (Christoper P.), Palmer, A. (Allyson), Satomi Miwa, Vermeij, Wilbert P., Passos, J.F. (João F.), Tchkonia, Tamar, Grellscheid, Sushma Nagaraja, Jurk, D. (Diana), Miwa, Satomi, Bird, Thomas G., Mikolaj Ogrodnik, Caroline L. Wilson, Thomas G. Bird, Mann, D.A. (Derek A.), Kirkland, James L., Mann, Derek A., Jurk, Diana, Vermeij, W.P. (Wilbert), Sander Barnhoorn, Miwa, S. (Satomi), Day, Christoper P., Burt, Alastair, Jan H J. Hoeijmakers, Bird, Thomas G.; id_orcid, Anstee, Quentin M., Dina Tiniakos, Diana Jurk, Alastair Burt, Tamar Tchkonia, Grellscheid, S.N. (Sushma Nagaraja), Christoper P. Day, Wilbert P. Vermeij   +61 more
core   +1 more source

Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides

, 2017
Yanmei Li,1,2 Ruibing Su,3 Shuqin Xu,2 Qingjun Huang,1 Haiyun Xu1,2 1The Mental Health Center, Shantou University Medical College, Shantou, Guangdong Province, People’s Republic of China; 2Department of Anatomy, Shantou University Medical College,
Li Y, Su R, Xu S, Huang Q, Xu H
core  

Imaging of hepatic steatosis and fatty sparing

, 2007
Radiology has gained importance in the non-invasive diagnosis of hepatic steatosis. Ultrasonography is usually the first imaging modality for the evaluation of hepatic steatosis.
KARÇAALTINCABA, MUSTURAY, Akhan, Okan
core   +1 more source

Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients

Kaohsiung Journal of Medical Sciences
Metabolic‐associated fatty liver disease (MAFLD) induced‐severe hepatic steatosis poses significant health risks. Early prediction of this condition is crucial for prompt intervention.
Yi‐Hsuan Lin, Ching‐Hsiang Wang, Yen‐Hsun Huang, Hsiao‐Chin Shen, Wei‐Kai Wu, Hsiao‐Yun Yeh, Chia‐Chang Huang, Chien‐Wei Su, Ying‐Ying Yang, Ming‐Shiang Wu, Han‐Chieh Lin, Ming‐Chih Hou   +11 more
doaj   +1 more source

Prevention of steatosis by hepatic JNK1

, 2016
Nonalcoholic steatosis (fatty liver) is a major cause of liver dysfunction that is associated with insulin resistance and metabolic syndrome. The cJun NH(2)-terminal kinase 1 (JNK1) signaling pathway is implicated in the pathogenesis of hepatic steatosis
Barrett, Tamera, Kim, Jason K, Gray, Susan, Davis, Roger J., Mora, Alfonso, Sabio, Guadalupe, Ko, Hwi Jin, Cavanagh-Kyros, Julie, Jun, John Y., Jung, Dae Young   +9 more
core   +1 more source

CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects

Advanced Science
Glucagon receptor (GCGR) agonism offers potentially greater effects on the mitigation of hepatic steatosis. However, its underlying mechanism is not fully understood. Here, it screened tetraspanin CD9 might medicate hepatic effects of GCGR agonist.
Yi Zheng, Yuren Wang, Xin Xiong, Linlin Zhang, Jiaran Zhu, Bangliang Huang, Xiufei Liu, Jinbo Liu, Zhiming Zhu, Gangyi Yang, Hua Qu, Hongting Zheng   +11 more
doaj   +1 more source

Hepatic Steatosis among Obese Children and Adolescents

, 2017
Background: Chronic liver disease, known as non- alcoholic fatty liver disease (NAFLD) is a metabolic complication of obesity. Hepatic steatosis is an entity in the spectrum of NAFLD, ranges from simple steatosis to advanced fibrosis and cirrhosis ...
Tahmina Begum, MA Baki, Rubaiya Islam, Sharmin Mahbuba, Fauzia Mohsin, Rumana Shelim   +5 more
core   +1 more source

Alcohol and HBV synergistically promote hepatic steatosis

, 2019
Background and aims: Hepatitis virus and alcohol are the main factors leading to liver damage. Synergy between hepatitis B virus (HBV) and alcohol in promoting liver cell damage and disease progression has been reported.
Zhan-Ming Li, Chao-Yue Kong, Shi-Long Zhang, Li-Shun Wang, Bing Han, Zheng-Yan Zhang   +5 more
core   +1 more source

Development and progression of hepatic steatosis during long-term glucocorticoid therapy in autoimmune hepatitis: multimodal evidence from biopsy, CAP, and ultrasound

Frontiers in Medicine
IntroductionAutoimmune hepatitis (AIH) is a chronic inflammatory liver disease treated with glucocorticoids (GCs). Long-term GCs therapy may increase the risk of hepatic steatosis.
Yijun Bao, Yijun Bao, Yu Zhang, Yu Zhang, Li Wang, Yongfeng Yang   +5 more
doaj   +1 more source